A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant

A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant

Drug induced liver injury is one of the most frequent reasons for stopping treatment and the main cause of the onset and progression of acute liver failure, requiring liver transplantation. In children antibacterial drugs are on the first place in terms of hepatotoxicity, and the hepatocellular type...

Full description

Bibliographic Details
Main Authors:	S. S. Postnikov, N. V. Teplova, V. V. Nikolaev, F, K. Abdullaev, Yu. N. Solontsov, A. E. Ermilin, M. N. Kostyleva, Anna N. Gracianskaya
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	drug induced liver injury anti-bacterial agents beta-lactams fluoroquinolones ciprofl oxacin ceftriaxone co-trimoxazol hepatotoxicity lesion frequency children
Online Access:	https://www.risksafety.ru/jour/article/view/143

Similar Items

Molecular epidemiology, hematological biomarker, associated risk factors and chemotherapeutic trials of ehrlichiosis in dogs in pakistan
by: Shoaib AHMAD, et al.
Published: (2022-08-01)

Divergent Relationships between Fecal Microbiota and Metabolome following Distinct Antibiotic-Induced Disruptions
by: Jocelyn M. Choo, et al.
Published: (2017-02-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

Liver Metabolomics and Inflammatory Profiles in Mouse Model of Fentanyl Overdose Treated with Beta-Lactams
by: Fawaz Alasmari, et al.
Published: (2023-08-01)

Antimicrobial Susceptibility Testing in <i>Pseudomonas aeruginosa</i> Biofilms: One Step Closer to a Standardized Method
by: Carmen Lozano, et al.
Published: (2020-12-01)

Evolution of Bacterial Persistence to Antibiotics during a 50,000-Generation Experiment in an Antibiotic-Free Environment
by: Hugo Mathé-Hubert, et al.
Published: (2022-03-01)

Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial
by: Phuong Nguyen Thi Thu, et al.
Published: (2021-09-01)

Antibiotic Resistance in Proteus mirabilis: Mechanism, Status, and Public Health Significance
by: Ebtehal Alqurashi, et al.
Published: (2022-09-01)

Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities
by: Samy M. El-Megharbel, et al.
Published: (2022-04-01)

Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in rats
by: Khaled A. Alhumaidha, et al.
Published: (2014-06-01)

Uncomplicated Urinary Tract Infections and Antibiotic Resistance—Epidemiological and Mechanistic Aspects
by: Bernd Wiedemann, et al.
Published: (2014-07-01)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
by: Shahbaz Ul Haq, et al.
Published: (2022-11-01)

Antibiotic Dosing in Chronic Kidney Disease
by: N. D. Bunyatyan, et al.
Published: (2021-12-01)

Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis
by: Eric Reid, et al.
Published: (2021-12-01)

Hepatotoxicity of atenolol therapy - A report of 2 cases
by: Somnath Mondal, et al.
Published: (2013-01-01)

Biochemistry of peptide antibiotics : recent advances in the biotechnology of beta-lactams and microbial bioactive peptides /
by: Kleinkauf, Horst, et al.
Published: (1990)

Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review
by: Andrea Marino, et al.
Published: (2022-01-01)

The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study
by: Boonmee P, et al.
Published: (2023-08-01)

The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
by: A. Abdulla, et al.
Published: (2020-01-01)

Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins
by: Varsha Gupta, et al.

Genetic characterization of clinical <I>Klebsiella</I> isolates circulating in Novosibirsk
by: A. V. Bardasheva, et al.
Published: (2021-04-01)

Evaluation of Antibiotic Biodegradation by a Versatile and Highly Active Recombinant Laccase from the Thermoalkaliphilic Bacterium <i>Bacillus</i> sp. FNT
by: Jorge Sánchez-SanMartín, et al.
Published: (2024-03-01)

Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01)

Mechanisms of antibiotic resistance in Haemophilus parainfluenzae
by: Regina E. Abotsi, et al.
Published: (2017-10-01)

Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
by: Lu-Yan Xu, et al.
Published: (2022-09-01)

Ampicillin Plus Ceftriaxone Regimen against <i>Enterococcus faecalis</i> Endocarditis: A Literature Review
by: Andrea Marino, et al.
Published: (2021-10-01)

Mechanism and yields in enzyme catalysed equilibrium and kinetically controlled synthesis of beta-lactam antibiotics, peptides and other condensation products /
by: 416857 Kasche, Volker

The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group
by: Margherita De Rosa, et al.
Published: (2021-01-01)

Evaluation of determination of 6-aminopenicillanic acid by p-dimethyl aminobenzaldehyde /
by: 408833 Shewale, Jaiprakash G., et al.

Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
by: Carmella Russo, et al.
Published: (2023-12-01)

Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
by: Nosheen Nasir, et al.
Published: (2019-09-01)

Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
by: W. R. P. L. I. Wijesooriya, et al.
Published: (2017-10-01)

Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study
by: Sarah Iuliano, et al.
Published: (2022-04-01)

Antibiotic allergy as a cause of hospitalization in adults: a hospital-based study in Ukraine
by: Oksana Horodnycha, et al.
Published: (2021-03-01)

Antibiotic-Related Adverse Drug Reactions in Patients Treated on the Dermatology Ward of Medical University of Gdańsk
by: Ewa Maria Sokolewicz, et al.
Published: (2021-09-01)

Investigation of Beta-Lactam and Tetracycline Group Antibiotic Residues in Bovine Liver, Kidney and Muscle Tissue
by: Sema Ağaoğlu, et al.
Published: (2021-12-01)

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
by: Jan-Willem C. Alffenaar, et al.
Published: (2011-11-01)

Expression of bovine annexin A4 in E. coli rescues cytokinesis blocked by beta-lactam antibiotics
by: Carl E. Creutz
Published: (2023-12-01)

Monitoring of multiresistant community-associated MRSA strains from patients with pathological processes of different localization
by: T. V. Sklyar, et al.
Published: (2018-04-01)

Hepatotoxicity induced by celecoxib and amlodipine
by: P Zinsser, et al.
Published: (2004-04-01)